Table 2.
Frequencies of KIR genes in HPV patients and controls.
| KIR genes | HPV patients N = 71 | Controls N = 118 | ||
|---|---|---|---|---|
| n | % | n | % | |
| 2DL1 | 68 | 95.8 | 116 | 98.3 |
| 2DL2 | 35 | 49.3 | 55 | 46.6 |
| 2DL3 | 63 | 88.7 | 104 | 88.1 |
| 2DL5 | 43 | 60.6 | 62 | 52.5 |
| 2DP1 | 68 | 95.8 | 115 | 97.4 |
| 2DS1 | 30 | 42.2 | 50 | 42.4 |
| 2DS2 | 37 | 52.1 | 57 | 48.3 |
| 2DS3 | 26 | 36.6 | 36 | 30.5 |
| 2DS4 | 65 | 91.5 | 108 | 91.5 |
| 2DS5 | 28 | 39.4 | 40 | 33.9 |
| 3DL1 | 65 | 91.5 | 109 | 92.4 |
| 3DS1 | 31 | 43.6 | 48 | 40.7 |
| 2DL4, 3DL2, 3DL3, and 3DP1 | 71 | 100 | 118 | 100 |
KIR gene frequencies were similar in both the groups (P ≥ 0.05).